发明名称 Phytoestrogen product of red clover and pharmaceutical uses thereof
摘要 The present invention provides compositions comprising optimized ratios of Red clover phytoestrogens as determined by a proprietary physiologically based pharmacokinetic and pharmacodynamic model. The compositions are useful for modulating bone remodeling, and prevention and treatment of osteoporosis.
申请公布号 US9333192(B2) 申请公布日期 2016.05.10
申请号 US201414242981 申请日期 2014.04.02
申请人 SINOVEDA CANADA, INC 发明人 Tam Yun Kau;Lin Yi-Chan James;Sloley Brian Duff;Tseng Chih-Yuan
分类号 A61K31/353;A61K36/48;G06F19/00 主分类号 A61K31/353
代理机构 Law Offices of Albert Wai-Kit Chan, PLLC 代理人 Law Offices of Albert Wai-Kit Chan, PLLC
主权项 1. An in vitro method of enhancing osteoblast differentiation, comprising the step of contacting osteoblasts with a composition comprising biochanin A and genistein, wherein the ratio of biochanin A to genistein is 9:1, and the composition comprises a dosage of total phytoestrogens ranging from 1 to 10 mg, wherein the concentration of biochanin A is 9 μM and the concentration of genistein is 1 μM.
地址 CA US